We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$746M
AUM Growth
-$106M
(-12%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
16.15%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
58
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$49.5M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$21.8M |
| 3 |
Walt Disney
DIS
|
+$16.1M |
| 4 |
Microsoft
MSFT
|
+$11M |
| 5 |
TSMC
TSM
|
+$8.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$6.55M |
| 2 |
Bausch Health
BHC
|
+$5.35M |
| 3 |
Digital Realty Trust
DLR
|
+$1.95M |
| 4 |
PennyMac Financial
PFSI
|
+$1.67M |
| 5 |
ConocoPhillips
COP
|
+$1.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.32% |
| 2 | Consumer Discretionary | 7.31% |
| 3 | Communication Services | 4.95% |
| 4 | Technology | 3.75% |
| 5 | Energy | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
Dynatrace
DT
$15.4B
| $1.57M | 0.21% |
+45,000
| New | +$1.74M |
|
77
CALL
Amylyx Pharmaceuticals
AMLX
$3.75B
| $1.53M | 0.21% |
+54,500
| New | +$1.36M |
|
78
CALL
Etsy
ETSY
$6.83B
| $1.5M | 0.2% |
15,000
| – | – |
|
|
SOS
79
CALL
SOS Limited
SOS
$14.1M
| $1.5M | 0.2% |
24,133
+23,650
| +4,896% | +$2.22M |
|
80
CALL
LivaNova
LIVN
$4.44B
| $1.47M | 0.2% |
29,000
-2,600
| -8% | -$154K |
|
81
PUT
The Mosaic Company
MOS
$7.96B
| $1.45M | 0.19% |
+30,000
| New | +$1.55M |
|
82
PUT
Generac Holdings
GNRC
$10.4B
| $1.43M | 0.19% |
8,000
| – | – |
|
83
PUT
Universal Insurance Holdings
UVE
$1.24B
| $1.38M | 0.19% |
+140,300
| New | +$1.68M |
|
|
CTXS
84
PUT
DELISTED
Citrix Systems Inc
CTXS
| $1.35M | 0.18% |
13,000
-200
| -2% | -$20.5K |
|
85
Ultragenyx Pharmaceutical
RARE
$1.34B
| $1.33M | 0.18% |
+32,173
| New | +$1.65M |
|
86
CALL
Cheniere Energy
LNG
$56.6B
| $1.33M | 0.18% |
+8,000
| New | +$1.21M |
|
|
CLR
87
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.29M | 0.17% |
+19,300
| New | +$1.3M |
|
|
TRQ
88
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $1.29M | 0.17% |
43,600
+33,100
| +315% | +$901K |
|
89
PUT
UnitedHealth
UNH
$344B
| $1.26M | 0.17% |
2,500
-5,000
| -67% | -$2.63M |
|
|
90
Dynatrace
DT
$15.4B
| $1.25M | 0.17% |
+36,000
| New | +$1.39M |
|
91
CALL
Enphase Energy
ENPH
$4.84B
| $1.22M | 0.16% |
+4,400
| New | +$1.19M |
|
92
PUT
Agnico Eagle Mines
AEM
$100B
| $1.16M | 0.16% |
27,400
-10,000
| -27% | -$429K |
|
93
PUT
ARK Innovation ETF
ARKK
$6.53B
| $1.05M | 0.14% |
+27,900
| New | +$1.24M |
|
94
CALL
Zillow
Z
$7.46B
| $1.04M | 0.14% |
36,400
| – | – |
|
|
VERV
95
CALL
DELISTED
Verve Therapeutics
VERV
| $1.03M | 0.14% |
+30,000
| New | +$957K |
|
|
SGEN
96
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.03M | 0.14% |
+7,500
| New | +$1.22M |
|
|
97
LivaNova
LIVN
$4.44B
| $1.02M | 0.14% |
20,000
-21,810
| -52% | -$1.29M |
|
|
98
PUT
LivaNova
LIVN
$4.44B
| $1.02M | 0.14% |
20,000
-23,600
| -54% | -$1.4M |
|
|
VERV
99
PUT
DELISTED
Verve Therapeutics
VERV
| $1.01M | 0.14% |
+29,500
| New | +$942K |
|
100
CALL
BioNTech
BNTX
$24.8B
| $1.01M | 0.14% |
+7,500
| New | +$1.15M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q3 2022 Portfolio in Review
As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
SG3 Management deployed $120M of net new capital in Q3 2022, opening 122 new positions and adding to 34 existing holdings. Its largest new stake was Tesla: 177,200 shares worth $47M.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 95% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was LivaNova, an estimated $1.29M trimmed.
- SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
- SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
- SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
- SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
- SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
- SG3 Management opened 122 new positions and closed 238 in Q3 2022.
- SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.
Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.